AN2 Therapeutics, Inc.
Recent Filings
All 346 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Eizen Joshua M | See Remarks | Sale | 2,819 @ $1.14 | 177,353 | Nov 4, 2025 |
| Prior Stephen David | Chief Strategy Officer | Sale | 765 @ $1.14 | 65,548 | Nov 4, 2025 |
| Marks Gilbert Lynn | — | Award / Grant | 10,367 | 63,749 | Oct 10, 2025 |
| Aziz Kabeer | — | Award / Grant | 10,367 | 40,919 | Oct 10, 2025 |
| Martin Patricia A. | — | Award / Grant | 3,274 | 13,255 | Oct 10, 2025 |
| Aziz Kabeer | — | Award / Grant | 11,875 | 30,552 | Jul 10, 2025 |
| Marks Gilbert Lynn | — | Award / Grant | 11,875 | 53,382 | Jul 10, 2025 |
| Martin Patricia A. | — | Award / Grant | 3,750 | 9,981 | Jul 10, 2025 |
| Easom Eric | Chief Executive Officer | Purchase | 10,000 @ $1.07 | 256,380 | Jun 2, 2025 |
| Leonard Braden Michael | — | Sale | 425,000 @ $1.01 | 3,224,432 | May 28, 2025 |